Europe Orthobiologics Market by Product (Bone Graft Substitutes, Bone Allografts, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User, by Geography - Analysis & Forecast to 2019
The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America.
Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. The companies operating in this region have been focusing on new product developments, mergers and acquisitions in order to establish their position in this highly competitive and rapidly growing market.
The report has profiled the leading players of this market along with the strategies (new product launches, partnerships, and joint ventures) done adopted by them to sustain and strengthen their position in the European orthobiologics market. The key players in the operating in the European orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the orthobiologics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. The companies operating in this region have been focusing on new product developments, mergers and acquisitions in order to establish their position in this highly competitive and rapidly growing market.
The report has profiled the leading players of this market along with the strategies (new product launches, partnerships, and joint ventures) done adopted by them to sustain and strengthen their position in the European orthobiologics market. The key players in the operating in the European orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the orthobiologics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies, exploit new clientele base and different pricing policies.
- Market Diversification: Extensive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market.
- Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the orthobiologics market.
- Product/Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET
2.2 ARRIVING AT THE ORTHOBIOLOGICS MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 EUROPEAN ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT
5.1 INTRODUCTION
5.2 EUROPEAN ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET
5.3 EUROPE BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY
5.4 EUROPE BONE ALLOGRAFTS MARKET, BY COUNTRY
5.5 EUROPE BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY
5.6 EUROPE STEM CELL THERAPY MARKET, BY COUNTRY
5.7 EUROPE VISCOSUPPLEMENTATION MARKET, BY COUNTRY
6 EUROPEAN ORTHOBIOLOGICS MARKET, BY END-USER
6.1 INTRODUCTION
6.2 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY
6.3 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS, BY COUNTRY
6.4 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY
7 EUROPEAN ORTHOBIOLOGICS MARKET, BY COUNTRY
7.1 INTRODUCTION
7.2 GERMANY ORTHOBIOLOGICS MARKET
7.2.1 GERMANY ORTHOBIOLOGICS MARKET, BY PRODUCT
7.2.2 GERMANY ORTHOBIOLOGICS MARKET, BY END-USER
7.3 FRANCE ORTHOBIOLOGICS MARKET
7.3.1 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT
7.3.2 FRANCE ORTHOBIOLOGICS MARKET, BY END-USER
7.4 ITALY ORTHOBIOLOGICS MARKET
7.4.1 ITALY ORTHOBIOLOGICS MARKET, BY PRODUCT
7.4.2 ITALY ORTHOBIOLOGICS MARKET, BY END-USER
7.5 SPAIN ORTHOBIOLOGICS MARKET
7.5.1 SPAIN ORTHOBIOLOGICS MARKET, BY PRODUCT
7.5.2 SPAIN ORTHOBIOLOGICS MARKET, BY END-USER
7.6 U.K. ORTHOBIOLOGICS MARKET
7.6.1 U.K.ORTHOBIOLOGICS MARKET, BY PRODUCT
7.6.2 U.K. ORTHOBIOLOGICS MARKET, BY END-USER
8 EUROPEAN ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT
8.3 MERGERS & ACQUISITIONS
8.4 NEW PRODUCT LAUNCHES
8.5 EXPANSIONS
8.6 AGREEMENTS
8.7 OTHER DEVELOPMENTS
9 EUROPEAN ORTHOBIOLOGICS MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC.
9.2 MEDTRONIC PLC
9.3 INTEGRA LIFE SCIENCES CORPORATION
9.4 STRYKER CORPORATION
9.5 ZIMMER, INC.
9.6 DEPUY SYNTHES
9.7 TORNIER, INC.
9.8 NUVASIVE, INC.
9.9 EXACTECH, INC.
9.10 GLOBUS MEDICAL INC.
9.11 WRIGHT MEDICAL TECHNOLOGY, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 REGULATORY FRAMEWORK
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 IMPACT ANALYSIS
10.2 RELATED REPORTS
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET
2.2 ARRIVING AT THE ORTHOBIOLOGICS MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.2.3 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 EUROPEAN ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT
5.1 INTRODUCTION
5.2 EUROPEAN ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET
5.3 EUROPE BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY
5.4 EUROPE BONE ALLOGRAFTS MARKET, BY COUNTRY
5.5 EUROPE BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY
5.6 EUROPE STEM CELL THERAPY MARKET, BY COUNTRY
5.7 EUROPE VISCOSUPPLEMENTATION MARKET, BY COUNTRY
6 EUROPEAN ORTHOBIOLOGICS MARKET, BY END-USER
6.1 INTRODUCTION
6.2 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY
6.3 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS, BY COUNTRY
6.4 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY
7 EUROPEAN ORTHOBIOLOGICS MARKET, BY COUNTRY
7.1 INTRODUCTION
7.2 GERMANY ORTHOBIOLOGICS MARKET
7.2.1 GERMANY ORTHOBIOLOGICS MARKET, BY PRODUCT
7.2.2 GERMANY ORTHOBIOLOGICS MARKET, BY END-USER
7.3 FRANCE ORTHOBIOLOGICS MARKET
7.3.1 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT
7.3.2 FRANCE ORTHOBIOLOGICS MARKET, BY END-USER
7.4 ITALY ORTHOBIOLOGICS MARKET
7.4.1 ITALY ORTHOBIOLOGICS MARKET, BY PRODUCT
7.4.2 ITALY ORTHOBIOLOGICS MARKET, BY END-USER
7.5 SPAIN ORTHOBIOLOGICS MARKET
7.5.1 SPAIN ORTHOBIOLOGICS MARKET, BY PRODUCT
7.5.2 SPAIN ORTHOBIOLOGICS MARKET, BY END-USER
7.6 U.K. ORTHOBIOLOGICS MARKET
7.6.1 U.K.ORTHOBIOLOGICS MARKET, BY PRODUCT
7.6.2 U.K. ORTHOBIOLOGICS MARKET, BY END-USER
8 EUROPEAN ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT
8.3 MERGERS & ACQUISITIONS
8.4 NEW PRODUCT LAUNCHES
8.5 EXPANSIONS
8.6 AGREEMENTS
8.7 OTHER DEVELOPMENTS
9 EUROPEAN ORTHOBIOLOGICS MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC.
9.2 MEDTRONIC PLC
9.3 INTEGRA LIFE SCIENCES CORPORATION
9.4 STRYKER CORPORATION
9.5 ZIMMER, INC.
9.6 DEPUY SYNTHES
9.7 TORNIER, INC.
9.8 NUVASIVE, INC.
9.9 EXACTECH, INC.
9.10 GLOBUS MEDICAL INC.
9.11 WRIGHT MEDICAL TECHNOLOGY, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 REGULATORY FRAMEWORK
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 IMPACT ANALYSIS
10.2 RELATED REPORTS
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.3.1 RT SNAPSHOTS
LIST OF TABLES
TABLE 1 EUROPEAN ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN)
TABLE 2 EUROPE: ORTHOBIOLOGICS MARKET: MACRO INDICATOR, BY COUNTRY, 2014
TABLE 3 EUROPE: ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (USD MN)
TABLE 4 EUROPEAN ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS
TABLE 5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 6 EUROPE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 7 EUROPE: ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
TABLE 8 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 9 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 10 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 11 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 12 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 13 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 14 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 15 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 16 EUROPE: OTHER END-USERS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 17 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 18 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013-2019 (USD MN)
TABLE 19 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 20 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 21 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 – 2019 (USD MN)
TABLE 22 ITALY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 23 ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 24 SPAIN: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 25 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
TABLE 26 U.K.: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 27 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
TABLE 28 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
TABLE 29 EUROPEAN ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS
TABLE 30 EUROPEAN ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES
TABLE 31 EUROPEAN ORTHOBIOLOGICS MARKET: EXPANSIONS
TABLE 32 EUROPEAN ORTHOBIOLOGICS MARKET: AGREEMENTS
TABLE 33 EUROPEAN ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS
TABLE 34 BIOMET, INC.: KEY FINANCIALS, 2011 - 2013 (USD MN)
TABLE 35 MEDTRONIC, PLC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 36 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010 - 2013 (USD MN)
TABLE 37 STRYKER CORPORATION: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 38 ZIMMER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 39 DEPUY SYNTHES: KEY FINANCIALS, 2011 - 2013 (USD MN)
TABLE 40 TORNIER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 41 NUVASIVE, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN)
TABLE 42 EXACTECH, INC.: KEY FINANCIALS, 2009 -2013 (USD MN)
TABLE 43 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009 -2013 (USD MN)
TABLE 44 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011 -2013 (USD MN)
TABLE 1 EUROPEAN ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN)
TABLE 2 EUROPE: ORTHOBIOLOGICS MARKET: MACRO INDICATOR, BY COUNTRY, 2014
TABLE 3 EUROPE: ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (USD MN)
TABLE 4 EUROPEAN ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS
TABLE 5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 6 EUROPE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 7 EUROPE: ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
TABLE 8 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 9 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 10 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 11 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 12 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 13 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 14 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 15 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 16 EUROPE: OTHER END-USERS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 17 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN)
TABLE 18 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013-2019 (USD MN)
TABLE 19 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 20 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 21 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 – 2019 (USD MN)
TABLE 22 ITALY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 23 ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN)
TABLE 24 SPAIN: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 25 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
TABLE 26 U.K.: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN)
TABLE 27 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
TABLE 28 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
TABLE 29 EUROPEAN ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS
TABLE 30 EUROPEAN ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES
TABLE 31 EUROPEAN ORTHOBIOLOGICS MARKET: EXPANSIONS
TABLE 32 EUROPEAN ORTHOBIOLOGICS MARKET: AGREEMENTS
TABLE 33 EUROPEAN ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS
TABLE 34 BIOMET, INC.: KEY FINANCIALS, 2011 - 2013 (USD MN)
TABLE 35 MEDTRONIC, PLC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 36 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010 - 2013 (USD MN)
TABLE 37 STRYKER CORPORATION: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 38 ZIMMER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 39 DEPUY SYNTHES: KEY FINANCIALS, 2011 - 2013 (USD MN)
TABLE 40 TORNIER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 41 NUVASIVE, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN)
TABLE 42 EXACTECH, INC.: KEY FINANCIALS, 2009 -2013 (USD MN)
TABLE 43 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009 -2013 (USD MN)
TABLE 44 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011 -2013 (USD MN)
LIST OF FIGURES
FIGURE 1 EUROPEAN ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 INTEGRATED RESEARCH METHODOLOGY
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 MACRO INDICATOR-BASED APPROACH AGING POPULATION 2014
FIGURE 7 EUROPEAN ORTHOBIOLOGICS MARKET SNAPSHOT, 2014
FIGURE 8 EUROPEAN ORTHOBIOLOGICS PRODUCTS, BY COUNTRY, 2014 (USD MN)
FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 10 EUROPE: ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET, 2013–2019 (USD MN)
FIGURE 11 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 12 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 13 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 14 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 15 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 16 EUROPE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 17 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 18 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 19 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 20 EUROPE: ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY COUNTRY, 2014-2019 (USD MN)
FIGURE 21 GERMANY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 GERMANY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
FIGURE 23 GERMANY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 24 GERMANY: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 26 FRANCE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 27 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
FIGURE 28 FRANCE ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 29 FRANCE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 30 FRANCE: ORTHOBIOLOGICS MARKET SHARE, BY END-USER, 2014 & 2019 (%)
FIGURE 31 ITALY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 32 ITALY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 33 ITALY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 34 ITALY ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 35 ITALY ORTHOBIOLOGICS MARKET: END USER SNAPSHOT
FIGURE 36 SPAIN: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 37 SPAIN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 38 SPAIN: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 39 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 40 SPAIN: ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT
FIGURE 41 U.K.: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 42 U.K.: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 43 U.K.: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 44 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 45 U.K.: ORTHOBIOLOGICS MARKET: END USER SNAPSHOT
FIGURE 46 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
FIGURE 47 ORTHOBIOLOGICS: COMPANY PRODUCT COVERAGE, 2013
FIGURE 48 BIOMET, INC.: REVENUE MIX, 2013 (%)
FIGURE 49 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 50 MEDTRONIC, PLC. REVENUE MIX, 2013 (%)
FIGURE 51 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 52 INTEGRA LIFE SCIENCES CORPORATION REVENUE MIX, 2013 (%)
FIGURE 53 CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2010-2013 (USD MN)
FIGURE 54 STRYKER CORPORATION REVENUE MIX, 2013 (%)
FIGURE 55 CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 56 ZIMMER, INC.: REVENUE MIX, 2013 (%)
FIGURE 57 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 58 DEPUY SYNTHES REVENUE MIX, 2013 (%)
FIGURE 59 TORNIER, INC.: REVENUE MIX 2013 (%)
FIGURE 60 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 61 NUVASIVE, INC.: REVENUE MIX 2013 (%)
FIGURE 62 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 63 EXACTECH, INC.: REVENUE MIX 2013 (%)
FIGURE 64 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 65 GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%)
FIGURE 66 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 67 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%)
FIGURE 68 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2011 - 2013 (USD MN)
FIGURE 1 EUROPEAN ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 INTEGRATED RESEARCH METHODOLOGY
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 MACRO INDICATOR-BASED APPROACH AGING POPULATION 2014
FIGURE 7 EUROPEAN ORTHOBIOLOGICS MARKET SNAPSHOT, 2014
FIGURE 8 EUROPEAN ORTHOBIOLOGICS PRODUCTS, BY COUNTRY, 2014 (USD MN)
FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 10 EUROPE: ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET, 2013–2019 (USD MN)
FIGURE 11 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 12 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 13 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 14 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 15 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 16 EUROPE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 17 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 18 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 19 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY, 2013 - 2019 (USD MN)
FIGURE 20 EUROPE: ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY COUNTRY, 2014-2019 (USD MN)
FIGURE 21 GERMANY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 GERMANY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
FIGURE 23 GERMANY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 24 GERMANY: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 26 FRANCE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 27 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
FIGURE 28 FRANCE ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 29 FRANCE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 30 FRANCE: ORTHOBIOLOGICS MARKET SHARE, BY END-USER, 2014 & 2019 (%)
FIGURE 31 ITALY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 32 ITALY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 33 ITALY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 34 ITALY ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 35 ITALY ORTHOBIOLOGICS MARKET: END USER SNAPSHOT
FIGURE 36 SPAIN: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 37 SPAIN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 38 SPAIN: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 39 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 40 SPAIN: ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT
FIGURE 41 U.K.: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 42 U.K.: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN)
FIGURE 43 U.K.: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
FIGURE 44 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN)
FIGURE 45 U.K.: ORTHOBIOLOGICS MARKET: END USER SNAPSHOT
FIGURE 46 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
FIGURE 47 ORTHOBIOLOGICS: COMPANY PRODUCT COVERAGE, 2013
FIGURE 48 BIOMET, INC.: REVENUE MIX, 2013 (%)
FIGURE 49 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 50 MEDTRONIC, PLC. REVENUE MIX, 2013 (%)
FIGURE 51 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 52 INTEGRA LIFE SCIENCES CORPORATION REVENUE MIX, 2013 (%)
FIGURE 53 CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2010-2013 (USD MN)
FIGURE 54 STRYKER CORPORATION REVENUE MIX, 2013 (%)
FIGURE 55 CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 56 ZIMMER, INC.: REVENUE MIX, 2013 (%)
FIGURE 57 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 58 DEPUY SYNTHES REVENUE MIX, 2013 (%)
FIGURE 59 TORNIER, INC.: REVENUE MIX 2013 (%)
FIGURE 60 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
FIGURE 61 NUVASIVE, INC.: REVENUE MIX 2013 (%)
FIGURE 62 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 63 EXACTECH, INC.: REVENUE MIX 2013 (%)
FIGURE 64 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 65 GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%)
FIGURE 66 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
FIGURE 67 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%)
FIGURE 68 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2011 - 2013 (USD MN)
